力大圖書
力 大 醫 學 圖 書 網          www.leaderbook.com.tw          歡迎使用  國民旅遊卡!!
帳號 密碼
加入會員 | 首頁 | 服務 | 行銷回應 | 代訂 | 購物車 | 預訂清單
Search
      圖書搜尋

 - 進階搜尋
  代訂書籍
  加購書籍專區
Classes
      圖書類別
運費(購買金額未滿NT$1000,請自行加上運費)
文化幣使用須知
台灣Pay使用須知
全支付使用須知
國民旅遊卡使用須知
購買注意事項與營業時間
力大圖書出版品
橘井文化系列叢書
免疫風濕科
內分泌科
內科(家醫科及實証醫學)
婦產科
眼科
病理科(檢驗科)
外科
耳鼻喉科(聽力和語言治療)
泌尿科
胸腔內科(重症醫學)
胸腔外科
腫瘤科(血液科)
放射腫瘤科
麻醉科(疼痛科)
獸醫科
神經外科
神經內科
小兒科
心臟內科
心臟血管外科
急診科
感染科
放射線科
核子醫科
牙科(口腔外科)
皮膚科(醫學美容)
精神科
胃腸科
骨科
腎臟科
整形外科
藥劑科
復健科(運動醫學)
護理科
食品營養
限量特價專區
解剖學(組織學)
基礎醫學科
醫學模型
醫學掛圖
SPRINGER庫存出清專區
 
 
 
-■ ■ ■ ■ ■ ■ 圖 書 介 紹
Textbook of Medical Oncology:Published in association with the European Society of Medical Oncology 3/e
-腫瘤科(血液科)
- 編號: 184184389X
- 作者:Franco Cavalli MD
- 原價-7654    - (熱賣價)6880      - 節省 ↓10%
- 加入購物車
推薦指數:
- 內容介紹
Textbook of Medical Oncology
Published in association with the European Society of Medical Oncology 3/e
Edited by: Franco Cavalli MD, FRCP, Heine H. Hansen MD, FRCP, Stan B. Kaye BSc, MD, FRCP, FRCR, FRSE
Publisher: Taylor & Francis
ISBN: 184184389X
Pub Date: 30 SEP 2004
Type: Hardback Book

' ... it offers excellent and up-to-date information for those who provide systemic treatment of cancer and others working in the field of oncology.' - New England Journal of Medicine (of the 2nd Edition)

Effective care of the cancer patient increasingly involves systemic treatment, and as the range of available therapeutic agents continues to expand, the oncologist must be fully aware of the rationale for choosing specific drugs and combinations. As a key source of reference, this third edition includes expanded material on targeted therapies and new chapters covering genetic screening and psycho-oncology and communication, keeping the medical oncologist at the forefront of cancer medicine.

Full Contributors:
Tanya Ahmad, Royal Marsden Hospital, London, UK, Dimitrios J Bafaloukos, Metropolitan Hospital, N. Falino, Greece, Peter Blake, Royal Marsden Hospital, London, UK, Marco Bonetti, Harvard School of Public Health, Boston, USA, Eduardo Bruera, The University of Texas MD Anderson Cancer Center, Houston, USA, Paolo G Casali, Istituto Nazionale Tumori, Milan, Italy, Raphael Catane, Sheba Medical Center, Tel Aviv, Israel, Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, Ian Chau, Royal Marsden Hospital, Sutton, UK, Nathan I Cherny, Shaare Zedek Medical Center, Jerusalem, Israel, Bertrand Coiffier, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France, Marco Colleoni, European Institute of Oncology, Milan, Italy, David Cunningham, Royal Marsden Hospital, Sutton, UK, Gedske Daugaard, Copenhagen University Hospital, The Netherlands, Elisabeth A Eisenhauer, Queen's University, Ontario, Canada, Ferry ALM Eskens, Erasmus University Medical Hospital, Rotterdam, The Netherlands, Martin F Fey, Inselspital and University, Berne, Switzerland, Rocío García-Carbonero, Hospital Severo Ochoa, Madrid, Spain, Richard D Gelber, Dana-Farber Cancer Institute, Boston, USA, Pierre Giglio, The University of Texas MD Anderson Cancer Center, Houston, USA Aron Goldhirsch, Oncology Institute of Southern Switzerland, Lugano, Switzerland, Martin Gore, Royal Marsden Hospital, London, UK, Heine H Hansen, The Finsen Center, Copenhagen, Denmark, Dieter Hoelzer, University of Frankfurt, Germany, Sandra J Horning, Stanford Center for Advanced Medicine, USA, Rosell Jenkins, The University of Texas MD Anderson Cancer Center, Houston, USA, Stan B Kaye, Royal Marsden Hospital, Sutton, UK, Hak Nam Kim, The University of Texas MD Anderson Cancer Center, Houston, USA, Paris A Kosmidis, Hygeia Hospital, Athens, Greece, Athanassios P Kyritsis, Ioannina Medical School, Greece, Victor A Levin, The University of Texas MD Anderson Cancer Center, Houston, USA, Lisa Licitra, Istituto Nazionale Tumori, Milan, Italy, Heinz Ludwig, Wilhelminenspital, Vienna, Austria, James Mackay, Institute of Child Health, London, UK, Silvia Marsoni, SENDO, Milan, Italy, Lone Nørgård Peterson, Copenhagen University Hospital, Denmark, Helle Pappot, The National University Hospital, Copenhagen, Denmark, Luis Paz-Ares, Hospital Universitario '12 de Octubre', Madrid, Spain, Piero Picci, Istituto Nazionale Tumori, Milan, Italy, Dirk Schrijvers, AZ Middleheim, Antwerp, Belgium, Gernot Seipelt, University of Frankfurt, Germany, Cristiana Sessa, Ospedale San Giovanni, Bellinzona, Switzerland, Stefan Sleijfer, Erasmus University Medical Center, Rotterdam, The Netherlands, Cora N Sternberg, Sam Camillo and Forlanini Hospitals, Rome, Italy, Gerrit Stoter, Erasmus University Medical Center, Rotterdam, The Netherlands, Marc Tischkowitz, Institute of Child Health, London, UK, Roy Vergis, Royal Marsden Hospital, London, UK, Jaap Verweij, Erasmus University Medical Center, Rotterdam, The Netherlands, Ronald de Wit, Rotterdam Cancer Institute, The Netherlands, Niklas Zojer, Wilhelminenspital, Vienna, Austria



歡迎使用國民旅遊卡
歡迎使用國民旅遊卡
其他相關書藉
  請輸入關鍵字
相 關 書 藉
Haematolymphoid Tumours: WHO Classification of Tumours 5/E 2024
- 腫瘤科(血液科)
- 作者:WHO Classification of Tumours Editori
Sickle Cell Disease, An Issue of Hematology/Oncology Clinics
- 腫瘤科(血液科)
- 作者:Cage S. Johnson
Platelets and Megakaryocytes Volume 1: Functional Assays
- 腫瘤科(血液科)
- 作者:Gibbins, Jonathan M.
Inherited Cancer Syndromes: Current Clinical Management
- 腫瘤科(血液科)
- 作者:Ellis, C. Neal
Consultative Thrombosis & Hemostasis
- 腫瘤科(血液科)
- 作者:Craig S. Kitchens, MD, Professor of Medi
--- more
[ 積點系統 ]
您已經累積多少點數您知道嗎?別忘了登錄會員,察看您的點數,獎品就等您來拿喲!
[ 訂購辦法 ]
您還不知道要在本網站如何購物嗎?我們將會提供給您訂購的方法及購物相關資訊喲!讓您彈指間取得想要的書藉。
 
      圖書搜尋         本網站購物機制使用 SSL+ 加密技術,請放心購物 Safe100%

| 加入會員 | 回首頁 | 服務中心 | 行銷回應 | 購物須知 | 會員條款 | 關於力大 | 權益申明 | 合作對象 |

本站內容為 力大圖書有限公司 所有,未經同意,請勿任意引用轉載
電話:(02)2733-2592 傳真:(02)2732-5743 E-mail:service@leaderbook.com.tw
力大圖書:台北市和平東路二段90巷2號4樓之2
Copyright 2002-2024 LeaderBook CO.,LTD All rights reserved.